4.3 Article

Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Remyelination can be extensive in multiple sclerosis despite a long disease course

R. Patani et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)

Article Clinical Neurology

Dual role of inflammation in CNS disease

Reinhard Hohlfeld et al.

NEUROLOGY (2007)

Article Ophthalmology

Improvement in conduction velocity after optic neuritis measured with the multifocal VEP

E. Bo Yang et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)

Article Clinical Neurology

Remyelination is extensive in a subset of multiple sclerosis patients

Peter Patrikios et al.

BRAIN (2006)

Article Multidisciplinary Sciences

Imaging of CNS myelin by positron-emission tomography

B Stankoff et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Clinical Neurology

Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria

CH Polman et al.

ANNALS OF NEUROLOGY (2005)

Article Clinical Neurology

Remyelinated lesions in multiple sclerosis -: Magnetic resonance image appearance

F Barkhof et al.

ARCHIVES OF NEUROLOGY (2003)

Article Ophthalmology

Normalisation of visual evoked potentials after optic neuritis

RR Hidajat et al.

DOCUMENTA OPHTHALMOLOGICA (2003)

Article Clinical Neurology

Remyelination in multiple sclerosis

W Brück et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)

Review Neurosciences

Why does remyelination fail in multiple sclerosis?

RJM Franklin

NATURE REVIEWS NEUROSCIENCE (2002)